Show simple item record

dc.contributor.author Lantos, PM
dc.contributor.author Charini, WA
dc.contributor.author Medoff, G
dc.contributor.author Moro, MH
dc.contributor.author Mushatt, DM
dc.contributor.author Parsonnet, J
dc.contributor.author Sanders, JW
dc.contributor.author Baker, CJ
dc.coverage.spatial United States
dc.date.accessioned 2011-06-21T17:27:21Z
dc.date.issued 2010-07-01
dc.identifier http://www.ncbi.nlm.nih.gov/pubmed/20504239
dc.identifier.citation Clin Infect Dis, 2010, 51 (1), pp. 1 - 5
dc.identifier.uri http://hdl.handle.net/10161/4154
dc.description.abstract In April 2008, the Infectious Diseases Society of America (IDSA) entered into an agreement with Connecticut Attorney General Richard Blumenthal to voluntarily undertake a special review of its 2006 Lyme disease guidelines. This agreement ended the Attorney General's investigation into the process by which the guidelines were developed. The IDSA agreed to convene an independent panel to conduct a one-time review of the guidelines. The Review Panel members, vetted by an ombudsman for potential conflicts of interest, reviewed the entirety of the 2006 guidelines, with particular attention to the recommendations devoted to post-Lyme disease syndromes. After multiple meetings, a public hearing, and extensive review of research and other information, the Review Panel concluded that the recommendations contained in the 2006 guidelines were medically and scientifically justified on the basis of all of the available evidence and that no changes to the guidelines were necessary.
dc.format.extent 1 - 5
dc.language eng
dc.language.iso en_US en_US
dc.relation.ispartof Clin Infect Dis
dc.relation.isversionof 10.1086/654809
dc.subject Anti-Bacterial Agents
dc.subject Antitrust Laws
dc.subject Conflict of Interest
dc.subject Connecticut
dc.subject Drug Administration Schedule
dc.subject Health Policy
dc.subject Humans
dc.subject Lyme Disease
dc.subject Practice Guidelines as Topic
dc.subject Societies, Medical
dc.subject United States
dc.title Final report of the Lyme disease review panel of the Infectious Diseases Society of America.
dc.title.alternative en_US
dc.type Journal Article
dc.description.version Version of Record en_US
duke.date.pubdate 2010-7-1 en_US
duke.description.endpage 5 en_US
duke.description.issue 1 en_US
duke.description.startpage 1 en_US
duke.description.volume 51 en_US
dc.relation.journal Clinical Infectious Diseases en_US
pubs.author-url http://www.ncbi.nlm.nih.gov/pubmed/20504239
pubs.issue 1
pubs.organisational-group /Duke
pubs.organisational-group /Duke/School of Medicine
pubs.organisational-group /Duke/School of Medicine/Clinical Science Departments
pubs.organisational-group /Duke/School of Medicine/Clinical Science Departments/Medicine
pubs.organisational-group /Duke/School of Medicine/Clinical Science Departments/Medicine/Medicine, Hospitalists
pubs.organisational-group /Duke/School of Medicine/Clinical Science Departments/Pediatrics
pubs.organisational-group /Duke/School of Medicine/Clinical Science Departments/Pediatrics/Pediatrics, Infectious Diseases
pubs.publication-status Published
pubs.volume 51
dc.identifier.eissn 1537-6591

Files in this item

This item appears in the following Collection(s)

Show simple item record